S. O'Reilly

发表

High-throughput kinome-RNAi screen identifies protein kinase R activator (PACT) as a novel genetic modifier of CUG foci integrity in myotonic dystrophy type 1 (DM1)

A. MacKenzie, S. Baird, F. Farooq, 2021, PloS one.

Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.

Kewei Chen, Eric M Reiman, Wendy Lee, 2010, Human molecular genetics.

Sodium Channel Inhibitors Reduce DMPK mRNA and Protein

A. MacKenzie, F. Farooq, J. Hadwen, 2015, Clinical and translational science.

Celecoxib increases SMN and survival in a severe spinal muscular atrophy mouse model via p38 pathway activation.

Duncan MacKenzie, Faraz Farooq, A. MacKenzie, 2013, Human molecular genetics.

Topotecan: what dose, what schedule, what route?

S. O'Reilly, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Screening of the Kinome Identifies PACT as a Novel Genetic Modifier of Foci Integrity in Myotonic Dystrophy type 1

S. O'Reilly, 2014 .

RNAi Screening of the Kinome Identifies PACT as a Novel Genetic Modifier of Foci Integrity in Myotonic Dystrophy type 1

S. O'Reilly, 2014 .

Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.

Jason J. Corneveaux, April N. Allen, Jill D. Gerber, 2010, Human molecular genetics.

Sodium Channel Inhibitors Reduce DMPK mRNA and Protein

A. MacKenzie, F. Farooq, L. Witherspoon, 2015, Clinical and translational science.